Add more content here...

Cancer Survivor Month

June is National Cancer Survivor Month, when we honor and remember those, who are affected by cancer to raise awareness for cancer survivorship and provide support for those currently battling the disease.

As part of our commitment to this important cause, we have collected a series of publications that can offer valuable insights on the treatment of Oncothermia as it can have a beneficial impact on survival time and quality of life.

Minnaar CA, Maposa I, Kotzen JA, Baeyens A. (2022)
Effects of modulated electro-hyperthermia (mEHT) on two and three year survival of locally advanced cervical cancer patients,

Cancers, 14, 656,

Ou J, Zhu X, Chen P, et al. (2020)
A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer,

Journal of Advanced Research, 24:175-182,

Fiorentini G, Sarti D, Casadei V, et.al. (2020)
Modulated electro-hyperthermia for the treatment of relapsed brain gliomas, in book Challenges and solutions of oncological hyperthermia, 
ed. Szasz A., Ch. 6, pp.110-125, Cambridge Scholars,
Fiorentini G, Sarti D, Casadei V, et al. (2019)
Modulated electro-hyperthermia as palliative treatment for pancreas cancer: A retrospective observational study on 106 patients,

Integrative Cancer Therapies, Vol. 18:1-8,

Ou J, Zhu X, Chen P, et al. (2020)
A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer,

Journal of Advanced Research, 24:175-182,

Iyikesici MS. (2020)
Long-term survival outcomes of metabolically supported chemotherapy with Gemcitabine-based or FOLFIRINOX regimen combined with Ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in metastatic pancreatic cancer,

Complement Med Res, 27(1):31-39,

Iyikesici MS. (2020)
Survival outcomes of metabolically supported chemotherapy combined with Ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in advanced gastric cancer,

Nigerian Journal of Clinical Practice, 23:734-40,

Parmar G. (2018)
Naturopathic Anti-Tumoral Treatment & 8 Year Survival Benefit Statistics: A Single-Centre Experience;

Oncothermia Journal 24:405-425,

Ou J, Zhu X, Lu Y, et.al. (2017)
The safety and pharmacokinetics of high dose intravenous ascorbic acid synergy with modulated electrohyperthermia in Chinese patients with stage III-IV non-small cell lung cancer,

European J Pharmaceutical Sciences, 109:412-418,

Pang CLK, Zhang X, Wang Z, et.al. (2017)
Local modulated electro-hyperthermia in combination with traditional Chinese medicine vs. intraperitoneal chemoinfusion for the treatment of peritoneal carcinomatosis with malignant ascites: A phase II randomized trial,

Molecular and Clinical Oncology, 6:723-732,

Schirrmacher V, Stücker W, Lulei M, et.al. (2015)
Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report;

Immunotherapy 7: 855–860,

Reimnitz U. (2010)
Cholangiocellular carcinomas: survival without symptoms with hyperthermia – A case study.

Oncothermia Journal 1:20-22,